Bari, Basel http://orcid.org/0000-0001-7553-2990
Corbeil, Marie-Andrée
MacNeill, Gail
Puebla-Barragan, Scarlett http://orcid.org/0000-0002-0276-3373
Vasquez, Arthur
Funding for this research was provided by:
CTC Communications
Article History
Received: 10 July 2023
Accepted: 14 September 2023
First Online: 30 September 2023
Declarations
:
: Basel Bari reports being a member of an advisory board or equivalent with Novo Nordisk, AstraZeneca, Boehringer Ingelheim, Sanofi, and Eli Lilly. Basel Bari also declares membership of a speakers’ bureau with Merck, Novo Nordisk, Sanofi, Boehringer Ingelheim, AstraZeneca, and Eli Lilly. Basel Bari has received or will be receiving a grant or an honorarium from CCRN, Sanofi, Boehringer Ingelheim, and Becton, Dickinson and Company (Embecta). Marie-Andrée Corbeil reports being a member of an advisory board as a speaker for Novo Nordisk, Eli Lilly, Sanofi, Abbott, Ascensia, Boehringer Ingelheim, Merck, AstraZeneca, Dexcom, and has taken part in an advisory board for Dexcom, Abbott, Novo Nordisk, AstraZeneca, and Amgen. She has or will be receiving an honorarium from Becton, Dickinson and Company (Embecta). Gail MacNeill is the chair of the FIT board of Canada which is sponsored by Embecta. Scarlett Puebla-Barragan reports that the company she works for, CTC Communications, has received funding from Embecta Canada. Arthur Vasquez reports acting as consultant for Novo Nordisk, Janssen Pharmaceuticals, AstraZeneca, Eli Lilly, and Becton, Dickinson and Company (Embecta). Arthur Vasquez also received an unrestricted grant from Janssen Pharmaceuticals and has been a paid speaker for Janssen Pharmaceuticals and AstraZeneca.
: The protocol for the Injection Technique Practice Reflective 2.0 study (Pro00062488) was reviewed and approved by the Advarra® institutional review board on May 5, 2022, and adhered to the principles of the Declaration of Helsinki of 1964 and its later amendments, Good Clinical Practice guidelines, and relevant laws and regulations. Advarra®, established in 1983, offers institutional review board (IRB), institutional biosafety committee (IBC), and research quality and compliance consulting services in North America. Prior to participating in the study, written informed consent was obtained from both patients and physicians.